Skip to main content

The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.

Publication ,  Journal Article
Itahana, Y; Han, R; Barbier, S; Lei, Z; Rozen, S; Itahana, K
Published in: Oncogene
April 2, 2015

Only humans and higher primates have high uric acid blood levels. Although high uric acid causes gout, it has been linked with human longevity because of its hypothetical antioxidant function. Recent studies reveal that p53 has significant roles in cellular metabolism. One example of this is an antioxidant function that potentially contributes to tumor suppression. Here, we reported a first beneficial link between p53 and uric acid. We identified the uric acid transporter SLC2A9 (also known as GLUT9) as a direct p53 target gene and a key downstream effector in the reduction of reactive oxygen species (ROS) through transporting uric acid as a source of antioxidant. Oxidative stress induced SLC2A9 expression in a p53-dependent manner, and inhibition of SLC2A9 by small interfering RNA (siRNA) or anti-gout drugs such as probenecid significantly increased ROS levels in an uric acid-dependent manner and greatly sensitized cancer cells to chemotherapeutic drugs. Conversely, expression of SLC2A9 reduced ROS and protected against DNA damage and cell death, suggesting its antioxidant function. The increased production of ROS because of p53 loss was rescued by SLC2A9 expression. Furthermore, decreased SLC2A9 expression was observed in several cancer types and was associated with a poorer prognosis. Our findings suggest that the p53-SLC2A9 pathway is a novel antioxidant mechanism that uses uric acid to maintain ROS homeostasis and prevent accumulation of ROS-associated damage that potentially contributes to cancer development.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Oncogene

DOI

EISSN

1476-5594

Publication Date

April 2, 2015

Volume

34

Issue

14

Start / End Page

1799 / 1810

Location

England

Related Subject Headings

  • Uric Acid
  • Tumor Suppressor Protein p53
  • Reactive Oxygen Species
  • RNA, Small Interfering
  • RNA Interference
  • Probenecid
  • Oxidative Stress
  • Oncology & Carcinogenesis
  • Neoplasms
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Itahana, Y., Han, R., Barbier, S., Lei, Z., Rozen, S., & Itahana, K. (2015). The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense. Oncogene, 34(14), 1799–1810. https://doi.org/10.1038/onc.2014.119
Itahana, Y., R. Han, S. Barbier, Z. Lei, S. Rozen, and K. Itahana. “The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.Oncogene 34, no. 14 (April 2, 2015): 1799–1810. https://doi.org/10.1038/onc.2014.119.
Itahana Y, Han R, Barbier S, Lei Z, Rozen S, Itahana K. The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense. Oncogene. 2015 Apr 2;34(14):1799–810.
Itahana, Y., et al. “The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense.Oncogene, vol. 34, no. 14, Apr. 2015, pp. 1799–810. Pubmed, doi:10.1038/onc.2014.119.
Itahana Y, Han R, Barbier S, Lei Z, Rozen S, Itahana K. The uric acid transporter SLC2A9 is a direct target gene of the tumor suppressor p53 contributing to antioxidant defense. Oncogene. 2015 Apr 2;34(14):1799–1810.

Published In

Oncogene

DOI

EISSN

1476-5594

Publication Date

April 2, 2015

Volume

34

Issue

14

Start / End Page

1799 / 1810

Location

England

Related Subject Headings

  • Uric Acid
  • Tumor Suppressor Protein p53
  • Reactive Oxygen Species
  • RNA, Small Interfering
  • RNA Interference
  • Probenecid
  • Oxidative Stress
  • Oncology & Carcinogenesis
  • Neoplasms
  • Humans